Dawen Zhao to Humans
This is a "connection" page, showing publications Dawen Zhao has written about Humans.
Connection Strength
0.524
-
Arledge CA, Sankepalle DM, Crowe WN, Liu Y, Wang L, Zhao D. Deep learning quantification of vascular pharmacokinetic parameters in mouse brain tumor models. Front Biosci (Landmark Ed). 2022 03 16; 27(3):99.
Score: 0.047
-
Liu Y, Zhao D. A novel nano-immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single-cell RNA-sequencing. Clin Transl Med. 2022 03; 12(3):e774.
Score: 0.047
-
Crowe W, Wang L, Zhang Z, Varagic J, Bourland JD, Chan MD, Habib AA, Zhao D. MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis. Int J Radiat Biol. 2019 03; 95(3):338-346.
Score: 0.038
-
Wang L, Habib AA, Mintz A, Li KC, Zhao D. Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential. Mol Imaging. 2017 01 01; 16:1536012117708722.
Score: 0.033
-
Zhang L, Habib AA, Zhao D. Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging. Oncotarget. 2016 Jun 21; 7(25):38693-38706.
Score: 0.032
-
Zhang L, Zhang Z, Mason RP, Sarkaria JN, Zhao D. Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs. Sci Rep. 2015 May 12; 5:9874.
Score: 0.029
-
Zhang L, Zhao D. Applications of nanoparticles for brain cancer imaging and therapy. J Biomed Nanotechnol. 2014 Sep; 10(9):1713-31.
Score: 0.028
-
Zhang L, Zhou H, Belzile O, Thorpe P, Zhao D. Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. J Control Release. 2014 Jun 10; 183:114-23.
Score: 0.027
-
Zhou H, Zhao D. Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI. J Vis Exp. 2014 Mar 06; (85).
Score: 0.027
-
Zhang L, Zhao D. Liposomal encapsulation enhances in vivo near infrared imaging of exposed phosphatidylserine in a mouse glioma model. Molecules. 2013 Nov 26; 18(12):14613-28.
Score: 0.027
-
Saha D, Dunn H, Zhou H, Harada H, Hiraoka M, Mason RP, Zhao D. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model. J Vis Exp. 2011 Oct 03; (56).
Score: 0.023
-
Zhou H, Luby-Phelps K, Mickey BE, Habib AA, Mason RP, Zhao D. Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One. 2009 Nov 30; 4(11):e8051.
Score: 0.020
-
Zhao D, Richer E, Antich PP, Mason RP. Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. FASEB J. 2008 Jul; 22(7):2445-51.
Score: 0.018
-
Zhao D, Ran S, Constantinescu A, Hahn EW, Mason RP. Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia. 2003 Jul-Aug; 5(4):308-18.
Score: 0.013
-
Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, Hatanpaa KJ, Garzon-Muvdi T, Koduru P, Nayab A, Jenks J, Sathe AA, Liu Y, Xing C, Wu SY, Chiang CM, Mukherjee B, Burma S, Wohlfeld B, Patel T, Mickey B, Abdullah K, Youssef M, Pan E, Gerber DE, Tian S, Sarkaria JN, McBrayer SK, Zhao D, Habib AA. EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation. Nat Cell Biol. 2022 Aug; 24(8):1291-1305.
Score: 0.012
-
Zhao D, Tomono Y, Tsuboi K, Nose T. Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary adenomas. Neurol Med Chir (Tokyo). 2000 Sep; 40(9):453-6; discussion 456-7.
Score: 0.011
-
Guo G, Gong K, Puliyappadamba VT, Panchani N, Pan E, Mukherjee B, Damanwalla Z, Bharia S, Hatanpaa KJ, Gerber DE, Mickey BE, Patel TR, Sarkaria JN, Zhao D, Burma S, Habib AA. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Neuro Oncol. 2019 12 17; 21(12):1529-1539.
Score: 0.010
-
Zhao D, Tomono Y, Nose T. Expression of P27kip1 and Ki-67 in pituitary adenomas: an investigation of marker of adenoma invasiveness. Acta Neurochir (Wien). 1999; 141(2):187-92.
Score: 0.009
-
Gong K, Guo G, Gerber DE, Gao B, Peyton M, Huang C, Minna JD, Hatanpaa KJ, Kernstine K, Cai L, Xie Y, Zhu H, Fattah FJ, Zhang S, Takahashi M, Mukherjee B, Burma S, Dowell J, Dao K, Papadimitrakopoulou VA, Olivas V, Bivona TG, Zhao D, Habib AA. TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer. J Clin Invest. 2018 06 01; 128(6):2500-2518.
Score: 0.009
-
Bhatt NB, Pandya DN, Dezarn WA, Marini FC, Zhao D, Gmeiner WH, Triozzi PL, Wadas TJ. Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes. Methods Mol Biol. 2018; 1790:197-208.
Score: 0.009
-
Guo G, Gong K, Ali S, Ali N, Shallwani S, Hatanpaa KJ, Pan E, Mickey B, Burma S, Wang DH, Kesari S, Sarkaria JN, Zhao D, Habib AA. A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. Nat Neurosci. 2017 Aug; 20(8):1074-1084.
Score: 0.009
-
Guo G, Gong K, Wohlfeld B, Hatanpaa KJ, Zhao D, Habib AA. Ligand-Independent EGFR Signaling. Cancer Res. 2015 Sep 01; 75(17):3436-41.
Score: 0.008
-
Wu Y, Hao G, Ramezani S, Saha D, Zhao D, Sun X, Sherry AD. [(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia. Contrast Media Mol Imaging. 2015 Nov-Dec; 10(6):465-72.
Score: 0.007
-
Tumati V, Mathur S, Song K, Hsieh JT, Zhao D, Takahashi M, Dobin T, Gandee L, Solberg TD, Habib AA, Saha D. Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy. Int J Oncol. 2013 May; 42(5):1613-9.
Score: 0.006
-
Mason RP, Zhao D, Liu L, Trawick ML, Pinney KG. A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment. Integr Biol (Camb). 2011 Apr; 3(4):375-87.
Score: 0.005
-
Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia. 2010 Sep; 12(9):675-84.
Score: 0.005
-
Park S, Zhao D, Hatanpaa KJ, Mickey BE, Saha D, Boothman DA, Story MD, Wong ET, Burma S, Georgescu MM, Rangnekar VM, Chauncey SS, Habib AA. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res. 2009 May 15; 69(10):4107-11.
Score: 0.005
-
Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res. 2009 Apr 01; 69(7):2809-16.
Score: 0.005
-
Yoshii Y, Saito A, Zhao DW, Nose T. Copper/zinc superoxide dismutase, nuclear DNA content, and progression in human gliomas. J Neurooncol. 1999 Apr; 42(2):103-8.
Score: 0.002